Buy-rated Stocks With Passive and Active Net Buying Tailwinds – Citi
Barclays Maintains Sotera Health Company(SHC.US) With Buy Rating, Maintains Target Price $18
KeyBanc Maintains Sotera Health Company(SHC.US) With Hold Rating
Piper Sandler Maintains Sotera Health Company(SHC.US) With Hold Rating, Raises Target Price to $15
Sotera Health (SHC) Gets a Buy From RBC Capital
Express News | Sotera Health Co : JP Morgan Cuts Target Price to $13 From $15
Sotera Health Down Nearly 5%, on Track for Lowest Close Since July -- Data Talk
Sotera Health: Perespective to Include Serviceable Addressable Market of $18B >SHC
Sotera Health: Fincl Plan to Expand Adjusted EBITDA Margins by at Least 50 Basis Points >SHC
Express News | Sotera Health Co Outlook 2025-2027 Financial Plan to Achieve Organic Compound Annual Revenue Growth Rate of 5% to 7%
Express News | Sotera Health Co - Now Sees Risk That Adj Ebitda for 2024 Could Fall Modestly Below Its Adj Ebitda Guidance Range
Sotera Health to Share Next Chapter of Growth at 2024 Investor Day
Greenlight Adds New Position in CNH Industrial, Boosts Peloton, Others in Q3
Sotera Health Is Maintained at Buy by Citigroup
Sotera Health Analyst Ratings
RBC Capital Maintains Sotera Health Company(SHC.US) With Buy Rating, Maintains Target Price $17
Jefferies Maintains Sotera Health Company(SHC.US) With Buy Rating, Raises Target Price to $18
Here's Why Sotera Health (NASDAQ:SHC) Has A Meaningful Debt Burden
Barclays Maintains Sotera Health Company(SHC.US) With Buy Rating, Raises Target Price to $18
Sotera Health (SHC) Gets a Buy From Barclays